GnRH for Infertility
This trial found that using a GnRH agonist in addition to progesterone during IVF cycles improves implantation and live birth rates.
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Side effects dataFrom 2009 Phase 2 trial • 36 Patients • NCT00586898
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
How many individuals are currently participating in this clinical experiment?
"Affirmative. According to the figures on clinicaltrials.gov, this research effort is actively trying to gather 350 participants from a single site. The trial was first listed 11/1/2015 and most recently updated 5/25/2022."
To what extent is GnRH a safe and viable therapeutic option?
"There is overwhelming evidence in favor of GnRH's safety, so it earned a score of 3."
Is this trial currently seeking participants?
"According to clinicaltrials.gov, this particular medical trial is in need of participants at the present time. This study was first made available on November 1st 2015 and has undergone its most recent update on May 25th 2022."
Who makes a suitable candidate for participating in this medical experiment?
"This trial aims to recruit 350 people between 18 and 40 who are struggling with infertility. To be considered, patients must meet these criteria."
What other research has been done on GnRH's efficacy in a clinical setting?
"Currently, there are 46 active GnRH-related clinical trials with 10 in their third phase. The majority of the studies for this hormone can be found at sites in Chicago, Illinois; however, across the entire US there is a total of 1321 trial centres conducting research."
Does the age bracket for this research include individuals over 40?
"This medical trial is only available to applicants aged between 18-40. Patients younger than 18 have 19 separate studies they can participate in, while those over 65 may join 59 different trials."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Most responsive sites:
- University Reproductive Associates: < 48 hours
Average response time
- < 2 Days